Drug intelligence / Profile preview

placebo + valdecoxib

Development stage
Discontinued
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination of placebo and valdecoxib. Placebo is an inert substance with no pharmacological activity, used as a control in clinical trials. Valdecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that acts as a selective cyclooxygenase-2 (COX-2) inhibitor, providing anti-inflammatory, analgesic, and antipyretic effects. It was primarily indicated for the treatment of osteoarthritis, rheumatoid arthritis, and primary dysmenorrhea but was withdrawn from major markets due to safety concerns related to cardiovascular events and serious skin reactions[1][2][4][5]. The combination "placebo + valdecoxib" would be used only in the context of clinical research or trials comparing active drug versus inactive control.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CA2 (Carbonic Anhydrase 2)CYP2D6 (Cytochrome P450 2D6)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP3A4 (Cytochrome P450 3A4)CYP2C19 (Cytochrome P450 2C19)

Beyond the preview

Go deeper on placebo + valdecoxib.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on placebo + valdecoxib.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call